Pharmacology

Action Mechanism of Action Reference
INHIBITOR Epidermal growth factor receptor erbB1 inhibitor PubMed

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Head and Neck Neoplasms 3 D006258 ClinicalTrials
Nasopharyngeal Neoplasms 3 D009303 ClinicalTrials
Carcinoma, Squamous Cell 3 D002294 ClinicalTrials
Esophageal Neoplasms 3 D004938 ClinicalTrials
Carcinoma 3 D002277 ClinicalTrials
Carcinoma, Squamous Cell 3 D002294 ClinicalTrials
Diffuse Intrinsic Pontine Glioma 3 D000080443 ClinicalTrials
Esophageal Neoplasms 3 D004938 ClinicalTrials
Pancreatic Neoplasms 3 D010190 ClinicalTrials
Glioblastoma 3 D005909 ClinicalTrials
Uterine Cervical Neoplasms 3 D002583 ClinicalTrials
Esophageal Neoplasms 3 D004938 ClinicalTrials
Breast Neoplasms 2 D001943 ClinicalTrials
Penile Neoplasms 2 D010412 ClinicalTrials
Glioma 2 D005910 ClinicalTrials
Carcinoma, Non-Small-Cell Lung 2 D002289 ClinicalTrials
Adenocarcinoma 2 D000230 ClinicalTrials
Stomach Neoplasms 2 D013274 ClinicalTrials
Colorectal Neoplasms 2 D015179 ClinicalTrials
Rectal Neoplasms 2 D012004 ClinicalTrials
Colorectal Neoplasms 2 D015179 ClinicalTrials
Hypopharyngeal Neoplasms 2 D007012 ClinicalTrials
Oropharyngeal Neoplasms 2 D009959 ClinicalTrials
Stomach Neoplasms 2 D013274 ClinicalTrials
Brain Stem Neoplasms 2 D020295 ClinicalTrials
Lung Neoplasms 2 D008175 ClinicalTrials
Squamous Cell Carcinoma of Head and Neck 2 D000077195 ClinicalTrials
Neoplasms 1 D009369 ClinicalTrials
Neoplasms 1 D009369 ClinicalTrials

Cross References

Resources Reference
CAS NUMBER 780758-10-3
ChEMBL CHEMBL2108359
FDA SRS 6NS400BXKH
Guide to Pharmacology 7988